hematologic disease: A disease involving the hematopoietic system.
Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue
DOID EFO Endpoint Browser PheWeb
D3_OTHDISLYMPHORETANDRETICULOHIST
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
118 |
4. Check minimum number of eventsNone |
118 |
5. Include endpoints |
118 |
6. Filter based on genotype QC (FinnGen only) |
118 |
Control definitions (FinnGen only)
- Control exclude
- D3_BLOODOTHER
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D70-D77
- Name in latin
- Aliqui morbi textus lymphoreticularis et systematis reticulohistiocytici
Similar endpoints
↥List of similar endpoints to
Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue
based on the number of shared cases.
Similar with more cases:
- Other diseases of blood and blood-forming organs, wide
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 896 | 420 | 473 |
| Only index persons | 719 | 332 | 387 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 34.32 | 35.37 | 33.34 |
| Only index persons | 41.02 | 42.89 | 39.42 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 118 | 55 | 63 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.03 |
| Median age at first event (years) | 52.10 | 52.89 | 51.41 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 104
- Matched controls
- 1041
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D76.1
ICD-10 Finland
Haemophagocytic lymphohistiocytosis
+∞
46.4
41
*
D76.3
ICD-10 Finland
Other histiocytosis syndromes
+∞
42.7
38
*
D76.00
ICD-10 Finland
Eosinophilic granuloma
+∞
31.9
29
*
D76.01
ICD-10 Finland
Histiocytosis X (chronic)
+∞
22.7
21
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
14.5
21.9
39
41
XW000
NOMESCO Finland
Bone marrow biopsy
31.3
21.4
28
12
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
26.8
20.4
28
14
H02AB09
ATC
hydrocortisone; systemic
32.7
14.9
19
7
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
7.1
14.6
40
84
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
86.5
14.0
15
*
JN4BD
NOMESCO Finland
Extensive body CT
8.9
13.1
29
43
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.9
13.1
70
307
R50.9
ICD-10 Finland
Fever, unspecified
6.3
12.8
38
87
WW500
NOMESCO Finland
Blood transfusion
19.0
12.7
19
12
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.8
11.5
36
87
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
67.1
10.9
12
*
JN4AD
NOMESCO Finland
Body CT examination
11.5
10.9
20
21
N17.9
ICD-10 Finland
Acute renal failure, unspecified
14.2
10.8
18
15
H02AB06
ATC
prednisolone; systemic
4.1
10.6
67
318
H02AB02
ATC
dexamethasone; systemic
8.6
10.5
23
33
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
10.8
10.0
19
21
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
13.3
10.0
17
15
D64.9
ICD-10 Finland
Anaemia, unspecified
7.9
10.0
23
36
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
11.7
9.4
17
17
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.1
9.4
46
169
UGC12
NOMESCO Finland
Flexible bronchoscopy
7.2
9.1
22
37
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
6.5
9.0
24
46
ZX120
NOMESCO Finland
Intravenous
7.1
8.9
22
38
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
6.0
8.8
25
52
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
6.9
8.8
22
39
A41.9
ICD-10 Finland
Sepsis, unspecified
14.5
8.7
14
11
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
97.6
8.5
9
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
+∞
8.4
8
*
D76.2
ICD-10 Finland
Haemophagocytic syndrome, infection-associated
+∞
8.4
8
*
D76.0
ICD-10 Finland
Langerhans' cell histiocytosis, not elsewhere classified
+∞
8.4
8
*
L03AA02
ATC
filgrastim; parenteral
36.5
8.2
10
*
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
13.3
7.8
13
11
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
11.3
7.8
14
14
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
6.8
7.7
19
33
TPX10
NOMESCO Finland
Implantation of vascular injection port
14.9
7.6
12
9
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
4.6
7.3
26
70
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
9.3
7.1
14
17
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
18.2
6.9
10
6
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
5.7
6.8
19
39
GD1AD
NOMESCO Finland
Thorax CT examination
9.7
6.8
13
15
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
9.7
6.8
13
15
M04AA01
ATC
allopurinol; systemic
4.8
6.6
22
55
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
9.1
6.6
13
16
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
15.6
6.5
10
7
JN6AD
NOMESCO Finland
CT of torso and neck
74.2
6.5
7
*
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
28.6
6.3
8
*
ZX108
NOMESCO Finland
Inhalation
28.6
6.3
8
*
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
28.6
6.3
8
*
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
+∞
6.3
6
*
102
Kela drug reimbursment
Diabetes insipidus
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3011412) CD3 cells [#/volume] in Blood
34
15
31.44
48.28
3.8
3.5
e9/l
0.9
1.1
—
24
5
(3023520) Reticulocytes [#/volume] in Blood
52
66
13.30
41.96
7.7
3.5
e9/l
72.0
73.4
0.06
43
49
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
40
34
17.29
41.68
2.6
1.9
g/l
1.6
1.6
0.07
30
27
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
42
6
107.04
40.14
7.7
1.8
u/ml
3986.2
566.5
—
42
6
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
26
10
33.07
38.30
3.9
4.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
30
19
20.83
36.16
2.3
2.9
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
24
10
29.87
34.25
2.4
6.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
39
44
12.75
33.59
2.5
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
36
6
85.13
33.32
2.0
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
31
28
14.66
30.65
2.6
2.7
—
—
—
0
0
(4035726)
48
86
8.72
28.43
2.5
1.4
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
21
10
25.33
28.30
3.5
3.5
e6/l
476.5
621.4
—
10
5
(3037756) Immunofixation for Serum or Plasma
22
12
22.31
28.04
1.6
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
27
24
14.29
26.77
3.8
1.8
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
23
16
17.61
26.09
1.5
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
26
23
14.22
25.81
3.2
1.8
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
25
22
14.15
24.85
1.5
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
30
9
43.99
24.80
1.9
1.8
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
23
19
14.79
23.67
4.0
1.8
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
21
15
16.81
23.39
1.5
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
23
20
14.04
22.95
1.6
2.4
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
23
20
14.04
22.95
1.3
1.9
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
54
135
6.53
22.56
11.1
8.3
mmol/l
1.1
1.2
0.44
54
124
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
23
21
13.36
22.25
1.3
1.9
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
21
17
14.81
21.79
1.5
1.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
19
14
15.98
20.71
2.2
1.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
27
36
9.43
19.99
1.7
2.0
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
36
69
7.07
19.41
12.2
5.9
%
0.1
0.0
0.59
27
26
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
22
23
11.53
19.40
1.8
1.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
36
72
6.76
18.56
12.4
5.8
%
1.0
0.4
1.08
27
27
(3002179) Metamyelocytes/100 leukocytes in Blood
34
66
6.83
18.01
12.5
5.7
%
0.7
0.3
1.18
24
18
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
22
7
38.11
17.77
2.2
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
17
14
14.02
17.29
4.2
1.6
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
16
12
15.27
17.13
1.5
1.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
16
0
+∞
17.08
2.2
0.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
79
332
5.17
16.87
24.4
6.3
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
52
157
5.13
16.86
12.9
6.1
mmol/l
0.8
0.8
0.09
52
146
(3000093) Morphology [Interpretation] in Blood Narrative
21
7
36.01
16.78
1.3
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
19
20
11.13
16.56
1.6
2.4
u/ml
294.9
137.5
—
10
11
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
27
9.25
15.82
2.5
1.1
g/l
6.6
7.6
1.34
15
21
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
27
9.25
15.82
2.5
1.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
27
9.25
15.82
2.5
1.1
g/l
3.5
3.6
0.08
15
21
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
16
14
13.06
15.65
1.5
1.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
32
67
6.18
15.56
11.1
5.9
%
0.0
0.0
0.48
24
23
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
15
12
14.17
15.44
4.7
1.8
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
22
31
8.49
15.40
1.8
1.5
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
98
516
6.31
15.12
23.9
6.7
e9/l
0.1
0.2
3.34
91
454
(21494434) Karyotype in Bone marrow
18
5
41.99
14.93
1.2
1.4
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
48
148
4.78
14.92
7.1
2.6
s
29.7
30.3
0.29
48
143
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
20
26
9.06
14.90
2.8
1.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
63
240
4.49
14.83
18.7
4.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
15
13
13.07
14.71
2.3
1.8
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
18
21
9.93
14.53
1.8
1.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
91
463
5.22
14.33
20.0
7.7
mmol/l
1.2
1.2
0.21
71
396
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
24
41
7.09
14.16
8.8
3.9
%
89.8
92.9
0.20
24
41
(3044290) Cell count panel - Cerebral spinal fluid
17
19
10.29
14.13
1.4
3.3
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
95
503
5.56
14.12
21.1
6.3
e9/l
0.6
0.6
0.36
90
435
(3006315) Basophils [#/volume] in Blood
95
503
5.56
14.12
21.0
6.4
e9/l
0.0
0.0
0.30
90
437
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
27
53
6.31
13.93
3.3
1.3
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
29
62
5.88
13.69
1.4
1.3
u/ml
77.1
178.8
1.90
24
57
(3037522) Nuclear Ab [Titer] in Serum
42
124
4.71
13.65
1.9
1.3
titre
560.0
561.3
0.00
11
32
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
13
10
14.49
13.59
4.7
1.3
pg
32.3
31.5
—
13
10
(3019198) Lymphocytes [#/volume] in Blood
95
518
5.28
13.19
22.0
6.4
e9/l
3.9
1.9
0.44
90
457
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
17
21
9.29
13.10
2.1
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
30
70
5.41
12.83
1.9
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
40
121
4.49
12.49
2.0
1.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
44
145
4.24
12.23
4.1
1.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
13
12
12.05
12.17
1.7
1.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
42
140
4.11
11.40
2.2
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
57
236
3.74
11.27
3.0
1.5
g/l
1.9
2.6
1.25
51
123
(3008757) Leukocyte morphology finding [Identifier] in Blood
12
11
12.03
11.24
8.6
6.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
47
173
3.85
11.04
2.6
1.9
—
—
—
0
0
(3026782) Osmolality of Urine
50
193
3.76
10.93
4.8
3.1
mosm/kgh2o
548.3
544.4
0.04
44
164
(3013650) Neutrophils [#/volume] in Blood by Automated count
97
584
4.71
10.64
37.1
9.8
e9/l
3.8
4.0
0.29
91
504
(3036481) Cortisol [Moles/volume] in Serum or Plasma
32
94
4.30
10.20
3.2
2.4
nmol/l
301.8
341.7
0.63
32
84
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
13
16
9.01
9.93
1.2
1.1
—
—
—
0
0
(4062490)
14
8
19.61
9.67
1.6
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
40
143
3.72
9.65
2.0
2.1
—
—
—
0
0
(44806118)
11
12
10.01
9.12
2.5
1.9
—
—
—
0
0
(44790047)
11
12
10.01
9.12
2.5
1.9
—
—
—
0
0
(44790049)
11
12
10.01
9.12
2.5
1.9
—
—
—
0
0
(44790048)
11
12
10.01
9.12
2.5
1.9
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
11
12
10.01
9.12
2.0
1.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
34
114
3.78
8.95
2.1
1.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
61
300
3.14
8.61
8.9
2.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
12
7
18.87
8.26
1.8
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
31
103
3.73
8.21
3.0
1.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
10
11
9.84
8.20
1.6
2.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
11
14
8.56
8.13
1.2
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
12
8
16.50
7.90
3.5
2.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
8
16.50
7.90
1.7
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
25
74
4.02
7.76
2.4
1.7
—
—
—
0
0
(3018418) pH of Serum or Plasma
57
283
2.96
7.72
12.8
3.7
ph
7.4
7.4
0.06
21
50
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
11
15
7.98
7.69
1.7
1.1
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
13
22
6.52
7.55
1.3
1.3
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
14
26
5.97
7.45
5.1
4.0
kpa
4.8
4.8
0.17
14
26
(3027315) Oxygen [Partial pressure] in Blood
14
26
5.97
7.45
4.9
4.0
kpa
8.6
9.1
0.33
14
26
(3016018) Differential panel - Cerebral spinal fluid
11
7
17.15
7.38
1.5
3.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
11
7
17.15
7.38
1.8
1.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
32
116
3.41
7.38
2.1
1.7
—
—
—
0
0
(3048879) Bone marrow aspiration report
7
0
+∞
7.36
1.6
0.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
10
5
21.65
7.26
2.9
1.4
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
10
13
8.31
7.23
1.4
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
29
100
3.52
7.21
3.1
1.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
11
8
14.99
7.04
1.2
1.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
13
24
5.96
6.94
3.8
4.8
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
11
17
7.03
6.90
6.7
4.0
%
53.0
60.8
0.69
11
17
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
15
32
5.22
6.90
10.2
3.3
%
212.3
206.7
0.08
15
32
(3016650) Hepatitis A virus Ab [Presence] in Serum
12
21
6.25
6.73
1.2
1.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
72
428
2.75
6.62
11.4
4.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
11
18
6.64
6.55
1.3
1.3
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
29
106
3.30
6.54
17.3
7.0
mmol/l
104.4
103.8
0.35
29
101
(3032080) INR in Blood by Coagulation assay
62
345
2.68
6.47
12.2
8.2
inr
1.1
1.2
0.76
23
95
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
6
0
+∞
6.30
2.5
0.0
ng/l
65.1
—
—
6
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
8
13.50
6.20
1.6
1.8
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
17
45
4.25
6.06
5.4
14.4
%
95.1
93.8
0.54
17
45
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
9
6
16.07
6.00
1.7
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
13
28
5.09
5.89
1.4
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
9
7
13.77
5.68
1.7
1.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
11
21
5.67
5.64
2.0
1.4
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
86
587
2.71
5.58
5.6
4.4
—
236.2
—
0
17
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
9
8
12.04
5.39
5.0
1.6
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
9
8
12.04
5.39
1.1
1.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
9
8
12.04
5.39
5.0
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
9
8
12.04
5.39
5.0
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
14
35
4.40
5.34
1.8
1.2
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
5
0
+∞
5.24
1.0
0.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
5
0
+∞
5.24
1.0
0.0
—
—
—
0
0
(3013862) HLA-DP [Type]
5
0
+∞
5.24
1.0
0.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
5
0
+∞
5.24
1.0
0.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
5
0
+∞
5.24
1.0
0.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
13
31
4.59
5.24
1.2
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
72
462
2.43
5.18
37.4
9.9
e9/l
0.0
0.0
0.71
65
364
(3000991) Gas panel - Venous blood
25
96
3.04
5.13
6.0
11.6
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
59
348
2.39
5.12
5.3
3.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
25
97
3.00
5.04
5.0
13.8
mmol/l
0.5
1.5
0.77
20
81
(3037467) Urinalysis macro (dipstick) panel - Urine
90
646
2.66
4.97
6.9
4.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
26
104
2.92
4.97
18.1
6.1
mmol/l
1.4
1.6
0.19
21
79
(40768806) Pleura Pathology biopsy report
9
10
9.62
4.87
1.1
2.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
43
224
2.45
4.87
8.2
2.3
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
24
93
2.98
4.84
5.2
14.2
kpa
4.6
5.2
2.38
24
87
(3027801) Oxygen [Partial pressure] in Arterial blood
24
93
2.98
4.84
5.2
14.3
kpa
11.3
12.0
0.37
24
88
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
23
87
3.04
4.83
5.3
5.3
mmol/l
1.7
1.5
0.08
18
63
(3015377) Calcium [Moles/volume] in Serum or Plasma
53
305
2.34
4.79
4.0
3.5
mmol/l
2.3
2.4
2.17
53
266
(40768804) Tissue Pathology biopsy report
58
347
2.32
4.79
2.7
1.9
—
—
—
0
0
(40758558) Short blood count panel - Blood
47
259
2.35
4.67
25.7
7.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
41
213
2.42
4.64
3.9
3.0
e6/l
7.0
4.4
0.41
34
188
(3037692) Legionella sp identified in Specimen by Organism specific culture
7
5
14.75
4.63
1.3
1.8
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
8
8
10.61
4.59
1.5
1.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
8
8
10.61
4.59
1.3
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
19
68
3.14
4.36
5.9
5.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
42
226
2.33
4.36
17.1
5.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
13
36
3.93
4.34
1.8
2.6
iu/l
18.2
23.5
—
8
28
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
22
87
2.88
4.26
17.3
8.6
mmol/l
24.0
24.6
0.36
22
87
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
11
7.70
3.92
1.5
1.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
51
309
2.15
3.90
5.4
3.6
e6/l
22.2
255.3
0.60
44
244
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
12
34
3.82
3.88
5.3
1.8
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
57
362
2.11
3.84
6.1
4.1
e6/l
29.8
42.0
0.34
48
261
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
8
9.21
3.82
1.1
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
5
12.53
3.80
6.0
2.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
5
12.53
3.80
6.0
2.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
5
12.53
3.80
1.5
1.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
6
5
12.53
3.80
5.8
2.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
6
5
12.53
3.80
5.8
2.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
5
12.53
3.80
6.0
2.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
6
5
12.53
3.80
5.8
2.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
5
12.53
3.80
6.0
2.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
47
279
2.14
3.76
5.4
3.4
e6/l
0.4
0.3
0.15
40
214
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
12
7.06
3.74
1.5
1.2
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
8
12
7.06
3.74
1.3
1.1
g/l
1.7
1.3
—
8
12
(40761536) Microorganisms panel - Urine sediment
20
81
2.77
3.70
8.7
4.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
9
17
5.63
3.58
1.3
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
6
6
10.44
3.53
1.3
1.0
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
45
275
2.03
3.25
5.2
3.3
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
8
15
5.63
3.25
1.3
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
7
11
6.68
3.23
1.4
1.0
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
12
39
3.31
3.19
9.7
3.1
mmol/l
25.1
24.8
0.13
12
39
(3013512) EKG study
43
261
2.02
3.15
5.1
3.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
43
262
2.01
3.11
3.8
2.8
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
9
21
4.55
3.06
1.3
1.9
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
5
5
10.36
3.00
1.8
2.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
5
10.36
3.00
1.6
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
52
347
1.89
2.84
2.2
1.9
pmol/l
79.4
95.9
2.68
35
184
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
5
6
8.63
2.77
2.0
3.8
%
102.6
81.3
—
5
6
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
10
6.25
2.73
2.7
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
10
6.25
2.73
2.7
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
10
6.25
2.73
2.7
1.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
51
344
1.85
2.66
5.2
3.8
ng/l
28.4
28.2
0.01
42
231
(3004119) Hemoglobin [Mass/volume] in Venous blood
13
50
2.80
2.63
29.3
3.2
g/l
117.8
132.4
1.18
13
50
(3020891) Body temperature
10
33
3.22
2.59
5.3
3.8
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
6
11
5.68
2.57
1.8
4.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
6
11
5.68
2.57
1.0
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
7
7.39
2.57
5.2
5.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
7
7.39
2.57
1.2
1.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
7
7.39
2.57
1.6
1.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
11
39
3.01
2.55
2.5
1.2
—
—
—
0
0
(3019225) pH of Specimen
16
70
2.49
2.54
11.4
3.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
40
253
1.88
2.53
2.3
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
21
105
2.22
2.50
1.6
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
29
166
1.99
2.44
4.6
3.3
ng/l
42.0
138.3
1.24
24
122
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
19
92
2.27
2.43
6.8
3.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
12
5.20
2.43
1.0
1.0
—
—
—
0
0
(3044889) 12 lead EKG panel
83
661
1.86
2.43
4.9
3.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
5
8
6.46
2.39
1.4
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
22
115
2.12
2.35
1.4
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
14
60
2.51
2.32
4.1
11.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
12
48
2.67
2.26
3.0
1.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
39
253
1.81
2.24
1.8
1.7
mmol/l
2.0
1.3
2.75
33
215
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
5
9
5.74
2.23
1.2
1.3
—
—
—
0
0
(4268621)
6
14
4.45
2.18
1.8
1.9
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
10
5.17
2.09
3.0
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
10
5.17
2.09
3.0
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
10
5.17
2.09
3.0
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
7
20
3.65
2.09
2.9
1.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
38
250
1.77
2.07
6.6
3.9
estimate
0.0
0.0
0.49
21
94
(3023419) Bacteria identified in Sputum by Culture
5
11
4.69
1.96
4.4
2.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
6
16
3.89
1.96
1.2
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
61
463
1.66
1.94
7.9
5.0
estimate
0.0
0.0
0.00
22
94
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
29
179
1.82
1.94
1.4
1.2
iu/ml
48.3
25.7
0.45
12
58
(3035350) Ketones [Presence] in Urine by Test strip
61
464
1.65
1.92
6.0
3.6
estimate
0.0
0.0
0.00
22
97
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
11
46
2.53
1.91
2.0
2.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
17
3.66
1.86
5.3
6.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
61
468
1.63
1.83
6.0
3.6
estimate
0.0
0.0
0.00
22
92
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
6
18
3.45
1.77
2.0
1.6
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
6
18
3.45
1.77
2.0
1.6
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
13
62
2.23
1.73
3.3
2.9
ng/l
92.8
105.1
0.11
13
56
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
14
69
2.17
1.73
25.3
7.6
mmol/l
23.6
23.7
0.03
14
64
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
8
32
2.61
1.63
3.4
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
49
365
1.59
1.61
6.2
3.6
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
7
27
2.69
1.54
1.6
1.6
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
15
3.43
1.54
5.0
3.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
9
37
2.55
1.51
1.3
1.2
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
9
39
2.41
1.46
20.0
3.7
%
39.6
52.5
—
9
39
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
108
987
2.11
1.46
52.1
12.9
mg/l
29.5
23.3
1.28
98
744
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
16
3.21
1.45
1.0
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
9
40
2.35
1.43
7.2
25.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
38
274
1.57
1.41
6.4
3.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
10
47
2.23
1.38
1.8
1.2
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
5
17
3.02
1.37
18.0
2.9
mmol/l
6.6
6.9
—
5
17
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
24
155
1.69
1.37
5.1
3.3
e6/l
1.1
1.8
0.45
15
93
(3016879) Cocaine [Presence] in Urine
8
39
2.13
1.18
7.6
1.7
—
—
—
0
0
(1002224) Polysomnography panel
0
36
0.00
1.16
0.0
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
12
66
1.91
1.14
1.6
2.8
ml/min/173m2
59.5
68.2
—
6
29
(4010399)
13
74
1.85
1.12
1.5
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
8
41
2.02
1.11
7.6
1.7
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
24
164
1.58
1.10
4.6
3.2
e6/l
1.2
0.9
0.30
15
102
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
98
890
1.60
1.09
5.2
4.4
mu/l
1.9
1.9
0.14
98
808
(3011288) Drugs identified in Urine by Screen method
7
35
2.06
1.02
9.9
2.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
23
161
1.53
0.96
1.3
1.3
u/ml
62.9
5.2
—
6
61
(3043409) Potassium [Moles/volume] in Arterial blood
6
27
2.29
0.95
5.3
3.7
mmol/l
3.7
3.9
—
6
20
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
16
103
1.64
0.93
2.4
5.2
ug/l
29.8
48.6
—
10
86
(1761482) Bacteria [#/volume] in Urine by Culture
6
28
2.20
0.93
6.2
5.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
8
42
1.97
0.90
7.6
1.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
8
42
1.97
0.90
7.6
1.7
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
8
42
1.97
0.90
7.6
1.7
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
15
96
1.64
0.89
1.8
2.5
u/l
29.2
29.5
0.03
15
81
(3019550) Sodium [Moles/volume] in Serum or Plasma
106
994
1.65
0.85
47.2
15.3
mmol/l
139.2
139.8
2.07
106
974
(3008152) Bicarbonate [Moles/volume] in Arterial blood
10
58
1.79
0.82
7.9
14.7
mmol/l
22.9
25.1
—
10
53
(1001926) Buprenorphine [Presence] in Urine by Screen method
6
33
1.86
0.80
9.8
1.7
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
106
1000
1.59
0.75
50.0
15.3
mmol/l
4.0
4.0
0.18
106
974
(3030981) Hyaline casts [#/volume] in Urine by Automated count
9
57
1.63
0.73
3.9
3.6
e6/l
0.3
0.1
—
9
57
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
97
910
1.37
0.60
5.8
4.4
mmol/l
5.9
5.9
0.02
89
836
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
18
133
1.42
0.59
1.7
1.6
—
—
—
0
0
(4094501)
0
23
0.00
0.59
0.0
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
99
933
1.38
0.58
40.9
14.2
%
36.2
40.5
2.90
71
738
(3020682) Albumin/Creatinine [Ratio] in Urine
33
271
1.30
0.57
7.2
3.9
mg/mmol
10.2
7.8
0.16
27
170
(3000492) Spirometry study
14
99
1.47
0.57
1.5
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
39
1.57
0.54
1.3
1.3
—
—
—
0
0
(3015736) pH of Urine
42
359
1.26
0.53
5.1
3.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
31
255
1.29
0.53
4.8
3.0
mg/l
78.7
62.7
0.13
26
167
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
27
218
1.31
0.53
1.4
1.7
—
—
—
0
0
(40761535) Cells panel - Urine sediment
9
64
1.44
0.53
4.0
3.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
6
92
0.63
0.44
1.5
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
13
96
1.40
0.44
1.5
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
5
32
1.59
0.43
3.4
3.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
26
216
1.26
0.41
4.5
3.4
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
0
15
0.00
0.41
0.0
12.4
—
6.4
—
0
15
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
21
253
0.79
0.38
3.5
4.1
%
22.2
23.1
—
10
102
(3000330) Specific gravity of Urine by Test strip
6
41
1.49
0.36
7.3
4.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
10
73
1.40
0.36
2.1
2.5
ug/l
6.5
5.3
—
10
67
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
12
92
1.34
0.33
14.0
7.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
108
1049
1.35
0.33
36.7
9.7
u/l
40.2
27.3
1.93
108
1017
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
84
881
0.84
0.32
6.0
5.5
mmol/mol
39.4
39.9
0.13
76
817
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
92
880
1.21
0.31
40.8
12.1
ml/min/173m2
83.1
84.3
0.20
85
709
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
92
955
0.83
0.29
5.3
4.8
mmol/l
2.5
2.7
1.30
85
883
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
16
131
1.26
0.29
1.5
2.2
%
1.6
1.4
0.30
11
120
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
6
81
0.73
0.25
1.8
1.7
—
—
—
0
0
(3008898) HLA-B27 [Presence]
5
39
1.29
0.23
1.0
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
8
102
0.77
0.22
1.1
1.2
—
—
—
0
0
(4281824)
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(4146454)
0
12
0.00
0.21
0.0
2.6
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
23
203
1.17
0.21
4.3
3.5
kg/l
1.0
1.0
—
6
26
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3019977) pH of Arterial blood
0
14
0.00
0.20
0.0
6.5
—
7.4
—
0
5
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
14
0.00
0.20
0.0
1.1
—
7.0
—
0
8
(3013139) Helicobacter pylori Ag [Presence] in Stool
6
51
1.19
0.19
1.5
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
11
131
0.82
0.18
3.7
2.1
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
110
1111
0.85
0.17
68.0
19.3
g/l
123.0
137.6
9.79
110
1100
(40761511) CBC panel - Blood by Automated count
105
1029
1.19
0.17
36.2
11.9
—
—
—
0
0
(3035941) MCH [Entitic mass]
110
1110
0.87
0.16
67.3
18.9
pg
30.1
30.2
0.12
110
1099
(3024731) MCV [Entitic volume]
110
1110
0.87
0.16
67.3
18.9
fl
90.7
90.2
0.36
110
1099
(3022217) INR in Platelet poor plasma by Coagulation assay
13
111
1.19
0.16
28.2
21.1
inr
1.2
1.3
—
5
14
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
91
934
0.89
0.16
5.0
4.4
mmol/l
1.2
1.4
3.51
85
862
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
92
939
0.91
0.11
5.0
4.4
mmol/l
4.3
4.6
1.50
86
874
(3022621) pH of Urine by Test strip
6
55
1.10
0.09
2.2
2.0
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
12
107
1.14
0.09
4.0
4.6
%
25.4
32.0
1.66
12
69
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
12
109
1.11
0.06
1.8
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
25
263
0.94
0.06
1.4
1.5
u/ml
0.7
1.3
—
5
61
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
71
698
1.04
0.04
3.6
3.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
11
117
0.93
0.02
3.7
1.9
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
37
363
1.03
0.01
3.1
2.8
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
0
5
0.00
0.00
0.0
6.2
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
5
0.00
0.00
0.0
1.0
—
10.3
—
0
5
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
0
5
0.00
0.00
0.0
6.2
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
1.2
—
0
5
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
6.0
—
224.6
—
0
5
(40765089) Chromosome analysis panel - Blood by G-banded
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
5.4
—
0.4
—
0
5
(3051593) INR in Capillary blood by Coagulation assay
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
5
52
0.96
0.00
1.0
1.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
9
0.00
0.00
0.0
3.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
0
8
0.00
0.00
0.0
2.0
—
17.7
—
0
8
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
5
54
0.92
0.00
1.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
5.3
—
61.6
—
0
7
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint D3_OTHDISLYMPHORETANDRETICULOHIST and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_OTHDISLYMPHORETANDRETICULOHIST | 4.294 [2.6, 7.1] | < 0.001 |
| Birth year | 0.998 [0.99, 1.01] | 0.683 |
During the follow-up period (1.1.1998 — 31.12.2019), 66 out of 345 females with D3_OTHDISLYMPHORETANDRETICULOHIST died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_OTHDISLYMPHORETANDRETICULOHIST | 3.517 [2.18, 5.68] | < 0.001 |
| Birth year | 0.99 [0.98, 1.0] | 0.029 |
During the follow-up period (1.1.1998 — 31.12.2019), 65 out of 367 males with D3_OTHDISLYMPHORETANDRETICULOHIST died.
Mortality risk
Mortality risk for people of age
years, who have D3_OTHDISLYMPHORETANDRETICULOHIST.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.342% | 0.823% |
| 5 | 2.472% | 4.244% |
| 10 | 5.771% | 10.339% |
| 15 | 11.403% | 19.136% |
| 20 | 20.89% | 30.915% |
Relationships between endpoints
↥Index endpoint: D3_OTHDISLYMPHORETANDRETICULOHIST – Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data